Weighted Average Number of Shares Outstanding, Diluted of COLLEGIUM PHARMACEUTICAL, INC from 31 Mar 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
COLLEGIUM PHARMACEUTICAL, INC quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Mar 2014 to 31 Dec 2025.
  • COLLEGIUM PHARMACEUTICAL, INC Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Dec 2025 was 40,076,457, a 0.08% decline year-over-year.
  • COLLEGIUM PHARMACEUTICAL, INC annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 39,701,693, a 1.8% decline from 2024.
  • COLLEGIUM PHARMACEUTICAL, INC annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 40,424,180, a 3.3% decline from 2023.
  • COLLEGIUM PHARMACEUTICAL, INC annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 41,788,125, a 24% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

COLLEGIUM PHARMACEUTICAL, INC Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 40,076,457 -33,192 -0.08% 01 Oct 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 39,439,890 -723,376 -1.8% 01 Jul 2025 30 Sep 2025 10-K 26 Feb 2026 2025 FY
Q2 2025 39,075,703 -1,307,991 -3.2% 01 Apr 2025 30 Jun 2025 10-K 26 Feb 2026 2025 FY
Q1 2025 32,840,153 -8,598,313 -21% 01 Jan 2025 31 Mar 2025 10-K 26 Feb 2026 2025 FY
Q4 2024 40,109,649 -1,170,332 -2.8% 01 Oct 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 40,163,266 -1,895,555 -4.5% 01 Jul 2024 30 Sep 2024 10-K 26 Feb 2026 2025 FY
Q2 2024 40,383,694 -2,466,258 -5.8% 01 Apr 2024 30 Jun 2024 10-K 26 Feb 2026 2025 FY
Q1 2024 41,438,466 +7,119,175 +21% 01 Jan 2024 31 Mar 2024 10-K 26 Feb 2026 2025 FY
Q4 2023 41,279,981 +7,697,779 +23% 01 Oct 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 42,058,821 +7,488,502 +22% 01 Jul 2023 30 Sep 2023 10-K 27 Feb 2025 2024 FY
Q2 2023 42,849,952 +8,848,399 +26% 01 Apr 2023 30 Jun 2023 10-K 27 Feb 2025 2024 FY
Q1 2023 34,319,291 +645,379 +1.9% 01 Jan 2023 31 Mar 2023 10-K 27 Feb 2025 2024 FY
Q4 2022 33,582,202 -541,107 -1.6% 01 Oct 2022 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 34,570,319 -1,690,855 -4.7% 01 Jul 2022 30 Sep 2022 10-K 22 Feb 2024 2023 FY
Q2 2022 34,001,553 -7,285,300 -18% 01 Apr 2022 30 Jun 2022 10-K 22 Feb 2024 2023 FY
Q1 2022 33,673,912 -7,486,180 -18% 01 Jan 2022 31 Mar 2022 10-K 22 Feb 2024 2023 FY
Q4 2021 34,123,309 -1,294,314 -3.7% 01 Oct 2021 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q3 2021 36,261,174 +1,191,986 +3.4% 01 Jul 2021 30 Sep 2021 10-K 23 Feb 2023 2022 FY
Q2 2021 41,286,853 +6,194,947 +18% 01 Apr 2021 30 Jun 2021 10-K 23 Feb 2023 2022 FY
Q1 2021 41,160,092 +6,090,399 +17% 01 Jan 2021 31 Mar 2021 10-K 23 Feb 2023 2022 FY
Q4 2020 35,417,623 +1,963,779 +5.9% 01 Oct 2020 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 35,069,188 +1,587,265 +4.7% 01 Jul 2020 30 Sep 2020 10-K 24 Feb 2022 2021 FY
Q2 2020 35,091,906 +1,694,197 +5.1% 01 Apr 2020 30 Jun 2020 10-K 24 Feb 2022 2021 FY
Q1 2020 35,069,693 +1,737,776 +5.2% 01 Jan 2020 31 Mar 2020 10-K 24 Feb 2022 2021 FY
Q4 2019 33,453,844 -315,921 -0.94% 01 Oct 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
Q3 2019 33,481,923 +469,749 +1.4% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2020 Q3
Q2 2019 33,397,709 +429,991 +1.3% 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2020 2020 Q2
Q1 2019 33,331,917 +428,243 +1.3% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q4 2018 33,769,765 01 Oct 2018 31 Dec 2018 10-K 27 Feb 2020 2019 FY
Q3 2018 33,012,174 01 Jul 2018 30 Sep 2018 10-K 27 Feb 2020 2019 FY
Q2 2018 32,967,718 01 Apr 2018 30 Jun 2018 10-K 27 Feb 2020 2019 FY
Q1 2018 32,903,674 01 Jan 2018 31 Mar 2018 10-K 27 Feb 2020 2019 FY
Q1 2016 23,130,153 +15,575,629 +206% 01 Jan 2016 31 Mar 2016 10-Q 11 May 2016 2016 Q1
Q4 2015 20,558,205 01 Oct 2015 31 Dec 2015 10-K 10 Mar 2017 2016 FY
Q3 2015 20,531,406 01 Jul 2015 30 Sep 2015 10-K 10 Mar 2017 2016 FY
Q2 2015 11,791,546 01 Apr 2015 30 Jun 2015 10-K 10 Mar 2017 2016 FY
Q1 2015 7,554,524 +6,641,908 +728% 01 Jan 2015 31 Mar 2015 10-K 10 Mar 2017 2016 FY
Q1 2014 912,616 01 Jan 2014 31 Mar 2014 10-Q/A 17 Jul 2015 2015 Q1

COLLEGIUM PHARMACEUTICAL, INC Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 39,701,693 -722,487 -1.8% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 40,424,180 -1,363,945 -3.3% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 41,788,125 +7,958,630 +24% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
2022 33,829,495 -7,216,310 -18% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 41,045,805 +5,894,452 +17% 01 Jan 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY
2020 35,151,353 +1,697,509 +5.1% 01 Jan 2020 31 Dec 2020 10-K 23 Feb 2023 2022 FY
2019 33,453,844 +500,036 +1.5% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
2018 32,953,808 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.